IRD is trading at $3.71, down 8.85% in pre-market.
🔴 Opus Genetics, Inc. is trading 8.85% down in pre-market
Opus Genetics, Inc.
Related News
IRD
🟢 Opus Genetics is trading 6.58% up in pre-market after Phase 3 enrollment completion
IRD
Opus Genetics Hits a Key Trial Milestone, But Can an Ultra-Rare Gene Therapy Justify Its $280 Million Bet?
IRD
🟢 Opus Genetics is trading 11% up in pre-market after completed Phase 3 OPGx-LCA5 enrollment
IRD
🟢 Opus Genetics is trading 7.45% up in pre-market — no clear catalyst identified
IRD